Media presence is a key part of making society aware of developments in biotechnology and its benefits. Asebio makes this platform available to members so they can share their press releases, alongside those the association posts regularly. If you are a journalist interested in learning more about the biotechnology sector, contact us at Asebio.
Merche Palomino, Director of Communication and Marketing
T. + 34 912 109 374 · firstname.lastname@example.org
The Spanish Association of Biocompanies (Asebio) has chosen the capital of Navarra to host the tenth edition of the event, which will be held from 29 September to 1 October.
Bayer Animal Health GmbH and VLPbio - The Vaccines Company S.L. have signed a global collaboration agreement to discover and develop a new generation of immunotherapeutic solutions that address the high demand for innovative treatment options in the field of veterinary medicine.
Potential approval would validate the use of Algenex’ CrisBio® technology for the manufacture of recombinant subunit vaccines
Asebio Investor Day, meeting point for specialized biotechnology investment
Within the framework of Bio €quity 2019, Asebio advances that investment in the biotech sector reached historical highs in 2018.